Abiopharma

🔍 Esposito Liliana (Executive)

Company: Wendy's Co (WEN)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 1,748 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 96,437.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 499 shares of Common Stock at $7.55 per share (Direct)
  Date: 2026-08-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 95,938.00 | transaction_form_type: 4
• Sold 1,748 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 78,771.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3, F4, F4
• Acquired 109,732 shares of Employee Stock Option (Right to Buy) at $7.55 per share (Derivative)
  Date: 2026-08-11 | Code: A | Expires: 2036-08-11 | equity_swap_involved: 0 | shares_owned_after: 109,732.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Acquired 15,894 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 94,665.00 | transaction_form_type: 4 | Footnotes: F2, F1, F7, F7

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
• F2: With tandem dividend equivalent rights and tax withholding rights.
• F3: Includes 296 dividend equivalent units that had accrued on the restricted stock units.
• F4: The restricted stock units were granted on August 11, 2023 and vested in three equal installments on the first, second and third anniversaries of the grant date. The first, second and third installments (including the related dividend equivalent units) vested on August 11, 2024, 2025 and 2026, respectively.
• F5: With tandem net exercise and tax withholding rights.
• F6: The option vests in three equal installments on August 11, 2027, 2028 and 2029, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.
• F7: The restricted stock units will vest in three equal installments on August 11, 2027, 2028 and 2029, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date.